L. Butler

Publications32
h-index12
Citations2,040
Highly Influential Citations69
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • W. Tilley
  • 291 Publications, 13,983 Citations
  • L. Butler
  • 122 Publications, 3,001 Citations
  • L. Selth
  • 105 Publications, 2,654 Citations
  • M. M. Centenera
  • 49 Publications, 1,479 Citations
  • Publications
  • Influence
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
Suberoylanilide hydroxamic acid (SAHA) is a potent inhibitor of histone deacetylases (HDACs) that causes growth arrest, differentiation, and/or apoptosis of many tumor types in vitro and in vivo.… Expand
  • 477
  • 23
Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
There is emerging evidence that the balance between estrogen receptor-alpha (ER(alpha)) and androgen receptor (AR) signaling is a critical determinant of growth in the normal and malignant breast. In… Expand
  • 291
  • 23
  • PDF
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
Suberoylanilide hydroxamic acid (SAHA) is the prototype of a family of hybrid polar compounds that induce growth arrest in transformed cells and show promise for the treatment of cancer. SAHA induces… Expand
  • 601
  • 12
  • PDF
Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli.
Despite the key roles of lymphatic vessels in homeostasis and disease, the cellular sources of signals that direct lymphatic vascular growth and patterning remain unknown. Using high-resolution… Expand
  • 23
  • 3
Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors
Purpose: Targeting Hsp90 has significant potential as a treatment for prostate cancer, but prototypical agents such as 17-allylamino-17 demethoxygeldanamycin (17-AAG) have been ineffective in… Expand
  • 88
  • 2
  • PDF
A patient‐derived explant (PDE) model of hormone‐dependent cancer
Breast and prostate cancer research to date has largely been predicated on the use of cell lines in vitro or in vivo. These limitations have led to the development of more clinically relevant models,… Expand
  • 36
  • 2
  • PDF
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase.
  • L. Butler, Y. Webb, +11 authors P. Marks
  • Biology, Medicine
  • Clinical cancer research : an official journal of…
  • 1 April 2001
PURPOSE We have synthesized a series of hybrid polar compounds that induce differentiation and/or apoptosis of various transformed cells. These agents are also potent inhibitors of histone… Expand
  • 122
  • 1
  • PDF
Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro.
PURPOSE A group of histone deacetylase inhibitors has been shown to be effective in suppressing the growth of a variety of transformed cell lines in vitro and in vivo. The effects of two of these… Expand
  • 55
  • 1
  • PDF
Differential effects of exogenous androgen and an androgen receptor antagonist in the peri- and postpubertal murine mammary gland.
There is emerging evidence that androgens inhibit proliferation of normal and malignant breast epithelial cells, but the actions of androgens in normal mammary gland morphogenesis are not well… Expand
  • 43
  • 1
Lipogenic effects of androgen signaling in normal and malignant prostate
Prostate cancer is an androgen-dependent cancer with unique metabolic features compared to many other solid tumors, and typically does not exhibit the “Warburg effect”. During malignant… Expand
  • 7
  • 1